Disease cohort study is commonly used to observe the relationship between a risk factor and the incidence of a disease or other health outcome. Strong analytical capabilities and quality data are vital to perform a successful disease cohort study.
Leveraging our analytical capabilities and integration of genomic data and clinical data (ADB), we serve as a platform and help our partners identify new targets for drug discovery or new patient populations that would benefit from repurposing an existing therapeutic method.
